Perceptive Advisors LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1224962) · Explore on the interactive board
Perceptive Advisors LLC disclosed 102 US equity positions worth $6.4bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is PRAX at 10.6% of the reported book, followed by SYRE, CELC. The top ten holdings are 48.9% of the book, and the portfolio behaves like about 28 equal-weight positions. Versus the prior filing it opened 23 new positions, added to 29, reduced 26 and exited 13. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Perceptive Advisors LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 23 new, 29 added, 26 reduced, 13 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 10.6% | $681.6m | 2,035,986 | 0% | held |
| 2 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 6.0% | $383.5m | 4,319,496 | 14% | added |
| 3 | CELC CELCUITY INC | Healthcare | 5.2% | $334.5m | 3,197,200 | 2% | added |
| 4 | ASND ASCENDIS PHARMA A/S | Healthcare | 4.8% | $310.4m | 1,163,721 | – | new |
| 5 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 4.5% | $287.2m | 2,586,295 | 9% | added |
| 6 | ROIV ROIVANT SCIENCES LTD | Healthcare | 4.4% | $286.1m | 8,085,461 | -2% | reduced |
| 7 | RLAY RELAY THERAPEUTICS INC | Healthcare | 4.1% | $263.9m | 14,106,187 | 45% | added |
| 8 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.3% | $213.2m | 3,752,574 | -9% | reduced |
| 9 | KARD KARDIGAN INC | 3.0% | $195.6m | 8,200,662 | – | new | |
| 10 | NUVALENT INC | 3.0% | $195.2m | 1,580,505 | 0% | held | |
| 11 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 2.8% | $177.7m | 4,373,974 | -1% | reduced |
| 12 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.7% | $173.6m | 1,308,113 | -15% | reduced |
| 13 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 2.3% | $149.7m | 8,334,882 | 1% | added |
| 14 | MGTX MEIRAGTX HLDGS PLC | Healthcare | 2.3% | $145.7m | 10,786,658 | 4% | added |
| 15 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 2.0% | $128.0m | 1,345,063 | -4% | reduced |
| 16 | INBX INHIBRX BIOSCIENCES INC | Healthcare | 1.9% | $123.0m | 1,297,763 | -10% | reduced |
| 17 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.9% | $120.4m | 981,879 | -20% | reduced |
| 18 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.8% | $118.9m | 11,906,646 | 0% | held |
| 19 | ZYME ZYMEWORKS INC | Healthcare | 1.7% | $109.3m | 4,182,953 | 19% | added |
| 20 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.6% | $105.6m | 3,377,000 | 318% | added |
| 21 | IMTX IMMATICS N.V | Healthcare | 1.6% | $105.2m | 10,383,456 | 0% | held |
| 22 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.6% | $104.8m | 4,320,422 | 16% | added |
| 23 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.6% | $103.1m | 10,308,888 | 39% | added |
| 24 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.5% | $98.8m | 527,600 | 104% | added |
| 25 | AVALYN PHARMACEUTICALS INC | 1.4% | $88.1m | 2,675,296 | – | new | |
| 26 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.9% | $59.7m | 2,689,235 | -42% | reduced |
| 27 | BIIB BIOGEN INC | Healthcare | 0.9% | $59.7m | 276,173 | – | new |
| 28 | IMVT IMMUNOVANT INC | Healthcare | 0.8% | $52.3m | 1,357,383 | -15% | reduced |
| 29 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.8% | $48.5m | 116,806 | – | new |
| 30 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.7% | $44.9m | 566,000 | 12% | added |
| 31 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.7% | $43.3m | 1,304,846 | 82% | added |
| 32 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.7% | $42.5m | 1,609,893 | -20% | reduced |
| 33 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 0.6% | $41.0m | 170,000 | 0% | held |
| 34 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 0.6% | $39.9m | 2,667,441 | 16% | added |
| 35 | SION SIONNA THERAPEUTICS INC | Healthcare | 0.6% | $39.8m | 905,000 | 37% | added |
| 36 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 0.6% | $39.1m | 10,439,185 | 3% | added |
| 37 | AORT ARTIVION INC | Healthcare | 0.6% | $39.0m | 1,737,290 | 6% | added |
| 38 | XFOR X4 PHARMACEUTICALS INC | 0.6% | $37.0m | 7,933,491 | 18% | added | |
| 39 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 0.5% | $34.6m | 398,385 | 697% | added |
| 40 | RGEN REPLIGEN CORP | Healthcare | 0.5% | $33.9m | 248,212 | -12% | reduced |
| 41 | AVR ANTERIS TECHNOLOGIES GLOBAL | 0.5% | $33.7m | 3,425,476 | 0% | held | |
| 42 | RAPP RAPPORT THERAPEUTICS INC | 0.5% | $32.2m | 773,342 | 15% | added | |
| 43 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 0.5% | $31.8m | 1,223,000 | 0% | held |
| 44 | CRL CHARLES RIV LABS INTL INC | Healthcare | 0.5% | $31.8m | 140,000 | – | new |
| 45 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 0.5% | $29.0m | 118,450 | -21% | reduced |
| 46 | DBVT DBV TECHNOLOGIES S A | 0.4% | $27.1m | 1,653,350 | 71% | added | |
| 47 | IRTC IRHYTHM HOLDINGS INC | Healthcare | 0.4% | $26.6m | 223,766 | 113% | added |
| 48 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 0.4% | $26.1m | 1,217,325 | 698% | added |
| 49 | SABS SAB BIOTHERAPEUTICS INC | 0.4% | $25.8m | 6,627,501 | 3% | added | |
| 50 | DHR DANAHER CORP DEL | Healthcare | 0.4% | $24.8m | 130,000 | – | new |
What did Perceptive Advisors LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| ASND ASCENDIS PHARMA A/S | 47.7% | $350.3m |
| CNTA CENTESSA PHARMACEUTICALS PLC | 28.5% | $208.9m |
| ENGENE HOLDINGS INC | 5.4% | $39.7m |
| DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 5.1% | $37.6m |
| DRUG BRIGHT MINDS BIOSCIENCES INC | 3.8% | $27.5m |
| BLTE BELITE BIO INC | 3.3% | $24.2m |
| EVMN EVOMMUNE INC | 1.4% | $10.3m |
| NMRA NEUMORA THERAPEUTICS INC. | 1.4% | $10.0m |
| NBIX NEUROCRINE BIOSCIENCES INC | 1.2% | $8.6m |
| IRD OPUS GENETICS INC | 1.1% | $8.4m |
| IKT INHIBIKASE THERAPEUTICS INC | 0.5% | $3.9m |
| APLSUSD APELLIS PHARMACEUTICALS INC | 0.4% | $3.3m |
| PTN PALATIN TECHNOLOGIES INC | 0.1% | $1.1m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 85.9% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Perceptive Advisors LLC's portfolio?
Across every quarter Perceptive Advisors LLC has filed, its median largest position is 11.8% of the book and its median top-ten weight is 50.4%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 12.0 completed holding spells, the median lasted 1.0 quarters; 102.0 positions are still open and their final length is unknown.